The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia

Neurocase

Volumn 14, Issue 3, 2008, Pages 271-275

  Imamura, Keiko ^a   Wada Isoe, Kenji ^a   Kowa, Hisanori ^a   Tanabe, Yoshio ^b   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cholinesterase inhibitor; eZIS; Hallucination; PDD; SPECT

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBIDOPA PLUS LEVODOPA; DONEPEZIL; LEVODOPA; QUETIAPINE; RISPERIDONE;

AGED; ARTICLE; ASSOCIATION CORTEX; BRAIN BLOOD FLOW; CASE REPORT; CINGULATE GYRUS; CLINICAL FEATURE; COGNITIVE DEFECT; DELUSION; DRUG DOSE INCREASE; DRUG EFFICACY; HALLUCINATION; HOSPITAL ADMISSION; HUMAN; IMAGING SYSTEM; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PARKINSON DISEASE; PSYCHOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

AGED; CEREBROVASCULAR CIRCULATION; DEMENTIA; GYRUS CINGULI; HUMANS; INDANS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PARKINSON DISEASE; PIPERIDINES; REGIONAL BLOOD FLOW; TREATMENT OUTCOME;

EID: 50249167175     PISSN: 13554794     EISSN: 14653656     Source Type: Journal    
DOI: 10.1080/13554790802269984     Document Type: Article

References (17)

1. Cilia, R., Marotta, G., Landi, A., Isaias, I. U., Vergani, F. Benti, R. et al. (2008) Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: A perfusion SPECT study. European Journal of Neurology, 15:1, pp. 22-28.
2. Desgranges, B., Baron, J. C., de lS, V., Petit-Taboue, M. C., Benali, K. Landeau, B. et al. (1998) The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain, 121, pp. 611-631.
3. Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C. Mizuno, Y. et al. (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22:12, pp. 1689-1707.
4. Fujishiro, H., Umegaki, H., Isojima, D., Akatsu, H., Iguchi, A. and Kosaka, K. (2006) Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies. Acta Neuropathologia, 111:2, pp. 109-114.
5. Fukuhara, R., Ikeda, M., Nebu, A., Kikuchi, T., Maki, N. Hokoishi, K. et al. (2001) Alteration of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport, 12:11, pp. 2473-2476.
6. Jueptner, M. and Weiller, C. (1995) Review: Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage, 2:2, pp. 148-156.
7. Matsuda, H. (2007) The role of neuroimaging in mild cognitive impairment. Neuropathology, 27:6, pp. 570-577.
8. Matsuda, H., Mizumura, S., Nagao, T., Ota, T., Iizuka, T. Nemoto, K. et al. (2007) Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR American Journal of Neuroradiology, 28:4, pp. 731-736.
9. Matsui, H., Nishinaka, K., Oda, M., Hara, N., Komatsu, K. Kubori, T. et al. (2007) Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study. Parkinsonism and Related Disorders, 13:3, pp. 174-181.
10. McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K. Anand, R. et al. (2000) Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet, 356:9247, pp. 2031-2036.
11. Mori, T., Ikeda, M., Fukuhara, R., Nestor, P. J. and Tanabe, H. (2006) Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology, 66:6, pp. 935-937.
12. Papapetropoulos, S. and Mash, D. C. (2005) Psychotic symptoms in Parkinson's disease. From description to etiology. Journal of Neurology, 252:7, pp. 753-764.
13. Rowan, E., McKeith, I. G., Saxby, B. K., O'Brien, J. T., Burn, D. Mosimann, U. et al. (2007) Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dementia & Geriatric Cognitive Disorders, 23:3, pp. 161-167.
14. Shimizu, S., Hanyu, H., Iwamoto, T., Koizumi, K. and Abe, K. (2006) SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease. Journal of Neuroimaging, 16:1, pp. 16-23.
15. Waragai, M., Yamada, T. and Matsuda, H. (2007) Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases. Journal of Neurological Science, 260:1, pp. 57-64.
16. Werber, E. A. and Rabey, J. M. (2001) The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia. Journal of Neural Transmission, 108:11, pp. 1319-1325.
17. Yoshida, T., Ha-Kawa, S., Yoshimura, M., Nobuhara, K., Kinoshita, T. and Sawada, S. (2007) Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease. Annals of Nuclear Medicine, 21:5, pp. 257-265.